Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the management of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://lilliayfz967283.kylieblog.com/39572015/retaglutide-a-promising-glp-1-receptor-agonist